Bivalent Ligands with Long Nanometer-Scale Flexible Linkers
Authors:
- 29 December 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 48 (2) , 264-275
Abstract
High-affinity ligands recognizing biomolecules with high specificity are crucial for drug discovery and biomolecule detection. We describe here a simple approach to preparing aptamer-based ligands with enhanced binding affinity. In this approach, two aptamer ligands with suboptimal binding properties are covalently linked with a long flexible linker to create a bivalent ligand with significantly improved binding affinity. We first used a simple oligonucleotide-based model, which mimicked the interaction between bivalent ligands and their target molecules, to investigate the principles governing the affinity enhancement. These experiments showed that as long as the individual ligands had at least submicromolar binding affinities, they could be linked with a nanometer-scale flexible linker to produce bivalent ligands with improved binding affinity and specificity. Furthermore, comparison of the experimental data with the bivalent ligand properties predicted by a wormlike chain model showed that this model provided a good approximation of the binding properties of nanometer-scale flexible bivalent ligands. To verify the practicality of bivalent ligands with nanometer-scale flexible linkers, we constructed aptamer-based bivalent ligands for human α-thrombin. In agreement with the predictions derived from the model system, the binding affinities and the anticlotting activities of thrombin bivalent ligands were significantly improved compared to those of the individual ligands.Keywords
This publication has 30 references indexed in Scilit:
- Alternative binding proteins: Affibody binding proteins developed from a small three‐helix bundle scaffoldThe FEBS Journal, 2008
- Aptamer therapeutics advanceCurrent Opinion in Chemical Biology, 2006
- Selecting and screening recombinant antibody librariesNature Biotechnology, 2005
- Aptamers: prospects in therapeutics and biomedicineFrontiers in Bioscience-Landmark, 2005
- In-vitro protein evolution by ribosome display and mRNA displayJournal of Immunological Methods, 2004
- A Bivalent Ligand (KDN-21) Reveals Spinal δ and κ Opioid Receptors Are Organized as Heterodimers That Give Rise to δ1 and κ2 Phenotypes. Selective Targeting of δ−κ HeterodimersJournal of Medicinal Chemistry, 2004
- Bivalent Ligands with Rigid Double-Stranded DNA Spacers Reveal Structural Constraints on Signaling by FcεRIThe Journal of Immunology, 2002
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990
- Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptorsJournal of Medicinal Chemistry, 1986